![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
1. The hepatic disposition of tilorone HCl, an antiviral and antitumour agent, was studied in male Wistar rats after intraduodenal administration.
2. A concentrative transfer into the liver occurred, the liver/portal blood concentration ratio being 120 or higher. The relationship between dose and hepatic concentration was linear.
3. Biliary excretion of tilorone was low and dose-related; whole blood concentration was also dose-related.
4. Neither hepatic concentration nor biliary excretion exhibited saturation over the dosage studied (6-174 mg/kg). The hepatic ‘depot’ of tilorone lacked the characteristics of a true ‘first-pass’ effect.